Venous Stents Market
Venous Stents Market Size, Share Analysis, By Application (Leg, Chest, Abdomen, Arm), By Disease Indication (Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, Others), By Technology (Iliac Vein Stent & Wall-stent Technologies), & By Region - Global Market Insights 2022 to 2032
Analysis of venous stents market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Venous Stents Market Outlook (2022 to 2032)
The global venous stents market size was valued at US$ 1.08 Billion in 2022, and is projected to reach US$ 2.44 Billion by 2032, growing at a CAGR (Compound Annual Growth Rate) of 8.5% during the forecast period from 2022 to 2032.
Venous stent technologies are classified into Iliac vein stent technologies and Wallstent technologies. Revenue from Wallstent technologies is expected to increase at a higher CAGR of 9% during the next 10 years. The purpose of Wallstent technology is to treat a constricted vein in the upper pelvic area that extends to the groyne area (iliofemoral vein). The Wallstent system usually consists of two parts: a stent composed of braided metallic (elgiloy) wire and a catheter device for over-the-wire stent delivery.
When the iliofemoral vein becomes constricted due to a buildup of fibrous blood clots along the vein's lining after a deep vein thrombosis or when the vein becomes compressed between a bone and an artery above it, Wallstent solution is used to widen the vein again (iliofemoral compression). These disorders often restrict blood circulation from the leg, causing swelling and walking pain.
Metal mesh tubes called venous stents are placed in the veins to treat chronic symptoms of venous disorders. Arterial stents and venous stents serve the same purpose. They come in a range of styles and dimensions.
Most often, a venous catheter is used to deliver stents compressed and to their intended location. Some catheters require the help of an inflated balloon, while others are self-expanded. These stents maintain the blocked or constricted veins open by expanding against them. They are flexible implants that support the vascular walls in both peripheral and central veins. Venous stent placement is typically done by surgeons in bigger, major veins such as those in the legs, belly, and chest.
Most stents are very difficult to remove if required and simply remain in place once they are implanted. Some stents can also be coated or made to release drugs gradually over time.
Venous stent devices are used to treat conditions such as chronic deep vein thrombosis, post-thrombotic syndrome, May-Thurner syndrome, and hemodialysis/arteriovenous fistulae.
Key venous stent manufacturers are heavily investing in R&D to come up with advanced flexible venous stents to treat several venous diseases. The sales of venous stents are also projected to increase as a result of the increasing senior population with target disorders and the rising spending power of individuals on healthcare.
| Report Attributes | Details |
|---|---|
| Venous Stents Market Size (2022E) | US$ 1.08 Billion |
| Forecasted Market Value (2032F) | US$ 2.44 Billion |
| Global Market Growth Rate (2022 to 2032) | 8.5% CAGR |
| China Market Growth Rate (2022 to 2032) | 12% CAGR |
| Japan Market Growth Rate (2022 to 2032) | 6% CAGR |
| Germany Market Growth Rate (2022 to 2032) | 7% CAGR |
| Key Companies Profiled | Becton, Dickinson Company; Boston Scientific Corporation; Cook Medical LLC; Gore Medical; Jotec GmbH; OptiMed Medizinische Instrumente GmbH |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why is There Such High Demand for Venous Stents?
“Rising Worldwide Cases of Chronic Symptomatic Venous Diseases”
- Deep vein thrombosis affects 13% to 31% of patients receiving medical critical care, according to a research titled "Incidence of proximal deep vein thrombosis in medical critical care patients" that was published in Thrombosis Journal in February 2022.
- Further, it also states that 10.1% was the incidence proportion, while 5.7% was the prevalence.
According to statistics, there has been a significant increase in the patient base, which is anticipated to spur the demand for leg vein stent surgeries.
- Also, as per research called "Prevalence of Post Thrombotic Syndrome in a Cohort of Upper Extremity Vein Thrombosis" which was published in the January 2022 issue of the Journal of Vascular Surgery: Venous and Lymphatic Disorders, 14.1% of cases of upper extremity PTS (UE-PTS) were caused by upper extremity venous thrombosis (UEVT).
Thus, rising cases of chronic symptomatic venous diseases are expected to boost sales of venous stent systems.
“Rising Incidence of Cardiovascular Disorders”
Angioplasty is a minimally-invasive procedure, whether it includes vascular stenting or not. When an artery or vein is too narrow or obstructed, angioplasty is utilised to increase blood flow. Instead of an operating room, it is typically performed in an interventional radiology room.
Also, promising minimally-invasive treatment for restricted arteries is performed during percutaneous transluminal angioplasty. Furthermore, top manufacturers are attempting to use high-quality drug-eluting venous stents to achieve excellent healthcare outcomes.
The main drawbacks of coated or bare metal stents have been addressed by the development of drug-eluting stents (DES).
- The Eluvia drug-eluting vascular stent device from Boston Scientific is getting a marketing boost since it can treat difficult lesions with excellent results.
Global cases of chronic cardiovascular diseases are rising primarily due to the increasing world’s senior population, as older people are more prone to experience heart-related disorders. Another significant problem for healthcare is hypertension. Older persons have higher amounts of total serum cholesterol, which makes them more vulnerable to several cardiovascular diseases.
Furthermore, obesity is a significant global risk factor for several heart diseases. Obesity or being overweight causes an excessive or improper buildup of fat within the artery wall, which can result in coronary heart disease and other health problems. As a result, controlling obesity and losing weight are essential steps in preventing cardiovascular disease. Thus, the above-mentioned factors are fuelling the sales of venous stents.
Which Challenges are Faced by Venous Stent Manufacturers?
“Strict Regulations for Product Approval”
Strict rules and policies for medical device approvals by respective authorities are expected to slow the production of stents.
Recent documentation of unintended negative patient outcomes has prompted the recall of several venous procedure devices from the market.
- For instance, Vascular Solutions Inc. recalled approximately 7,000 units of their venture catheters in 2017 because the catheter tip had extra material that could have split during surgeries and caused blood clots.
To prevent any anomaly from arising during the trials, leading medical device manufacturers rigorously scrutinize and test each product in the lab. This reduces the effective shelf life of important surgical tools, thus restricting the long-term growth potential of venous stents.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
What is Outlook for Venous Stent Sales in the United States?
“Production of Advanced Venous Stents by Top Companies”
The United States currently dominates the North American venous stents market. The existence of major firms and their use of cutting-edge medical technologies to manufacture stents are primarily responsible for the larger share.
In addition, a well-developed healthcare infrastructure and significant financial investments by the government in the healthcare sector are some of the major drivers boosting venous stents market growth. Furthermore, supportive government policies and a rise in research collaboration agreements are among the factors likely to boost demand for venous stents.
- Deep vein thrombosis (DVT) or pulmonary embolism (PE) may affect 900,000 individuals annually in the United States, according to the Centers for Diseases Control and Prevention in June 2022.
- One-third to fifty percent of patients who experience a DVT may experience long-term effects (post-thrombotic syndrome), which include edoema, pain, discoloration, and scaling in the affected leg.
Why is Demand for Venous Stents Surging in European Countries?
“Growing Prevalence of Heart-related Disorders in Europe”
The rising rate of the senior population coupled with increasing cases of cardiovascular disorders in European countries such as the U.K., Germany, and Italy is expected to increase sales of venous stents.
- According to British Heart Foundation, currently, more than 7 million people in the U.K. are living with cardiovascular diseases (CVDs).
- According to Max Planck Institute, CVDs are the most common cause of death in Germany, and more than 1 million people are living with CVDs in the nation.
Sales of venous stents in Germany are predicted to expand at a CAGR of 7% during the forecast period. Thus, rising incidences of cardiovascular disorders in European nations are expected to fuel demand for venous stents.
What’s Benefitting Manufacturers of Venous Stents in Japan & Korea?
“Rapidly Developing Healthcare Infrastructure & Innovations in Medical Devices”
Japan and South Korea are leading markets for venous stents, due to advancing healthcare infrastructure, increasing cases related to stress and hypertension, and rising incidences of heart attacks due to running lifestyle.
Manufacturers of venous stents are attracted to Japan and South Korea due to beneficial government policies towards healthcare. In recent years, Korean manufacturers are creating sophisticated medical gadgets in response to end-user requests to achieve maximum productivity.
Additionally, these producers are introducing advanced medical consumables for the efficient treatment of people with coronary disease, which is predicted to increase the demand for venous stents in South Korea.
Category-wise Analysis
For Which Disease Treatment are Venous Stents Most Widely Used?
“Sales of Venous Stents Highest for Chronic Deep Vein Thrombosis Treatment”
When a (thrombus) blood clot develops in one or even more deep veins in the body, commonly in the legs, is known as chronic deep vein thrombosis. Leg pain or edoema may be brought on by deep vein thrombosis.
In some cases, there are no obvious signs. The rising incidence of chronic deep vein thrombosis and new stent device introductions by the major market participants are the main factors boosting the demand for venous stents.
- A paper titled "Deep Vein Thrombosis" which was produced in the National Library of Medicine in August 2021 states that the incidence of DVT in lower limbs is 1 case per 1000 persons, with a prevalence rate of DVT predicted to be 80 cases per 100,000 people. In the US, venous thrombosis affects over 200,000 persons annually; pulmonary embolism aggravates 50,000 of these cases.
- Iliofemoral venous outflow blockage is now most usually treated with stenting, according to the research paper "Contralateral deep-vein thrombosis in lliac vein stenting - Incidence, etiology, and prevention" printed in the Indian Journal Vascular and Endovascular Surgery. Patients with post-thrombotic syndrome (PTS), which develops after a prior deep vein thrombosis, can use it to treat severe ulcer healing situations as well as the signs of ongoing pain and swelling.
Thus, the above-mentioned studies show that the rising prevalence of chronic deep vein thrombosis is boosting the production of venous stents.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Major venous stent companies are concentrated on launching upgraded stents and innovation in technologies to accelerate sales growth.
- The Medtronic venous stent namely "Abre venous self-expanding stent system" has been approved by the US Food and Drug Administration (FDA) for use in October 2020. When a patient has symptomatic deep venous obstruction, also known as iliofemoral venous outflow obstruction, this device is suggested for treatment.
- The "S.M.A.R.T. RADIANZ Vascular Stent System" from Cordis, a self-expanding stent specially developed for radial peripheral operations, obtained FDA approval in March 2022. The S.M.A.R.T. RADIANZ Vascular Stent System makes it easier to accurately and effectively insert stents in the superficial femoral (SFA) and iliac arteries.
Key Segments of Venous Stents Industry Research
-
By Application :
- Leg
- Chest
- Abdomen
- Arm
-
By Disease Indication :
- Chronic Deep Vein Thrombosis
- Post Thrombotic Syndrome
- May-Thurner Syndrome
- Hemodialysis/Arteriovenous Fistulae
-
By Technology :
- Iliac Vein Stent Technologies
- Wallstent Technologies
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Mn) Analysis 2017 to 2021 and Forecast, 2022 to 2032
- 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
- 6.1. Leg
- 6.2. Chest
- 6.3. Abdomen
- 6.4. Arm
- 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Disease Indication
- 7.1. Chronic Deep Vein Thrombosis
- 7.2. Post Thrombotic Syndrome
- 7.3. May-Thurner Syndrome
- 7.4. Hemodialysis/Arteriovenous Fistulae
- 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Technology
- 8.1. Iliac Vein Stent Technologies
- 8.2. Wallstent Technologies
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 14. South Asia & Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. Becton, Dickinson Company
- 17.2. Boston Scientific Corporation
- 17.3. Cook Medical LLC
- 17.4. Gore Medical
- 17.5. Jotec GmbH
- 17.6. OptiMed Medizinische Instrumente GmbH
- 18. Assumptions and Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 02: Global Market Value (US$ Mn) Analysis, by Application, 2022 to 2032
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032
Table 04: Global Market Value (US$ Mn) Analysis, by Disease Indication, 2017 to 2021
Table 05: Global Market Value (US$ Mn) Analysis, by Disease Indication, 2022 to 2032
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Disease Indication, 2022 to 2032
Table 07: Global Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 08: Global Market Value (US$ Mn) Analysis, by Technology, 2022 to 2032
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2032
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2017 to 2021
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2022 to 2032
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2022 to 2032
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2022 to 2032
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032
Table 16: North America Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 17: North America Market Value (US$ Mn) Analysis, by Application, 2022 to 2032
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032
Table 19: North America Market Value (US$ Mn) Analysis, by Disease Indication, 2017 to 2021
Table 20: North America Market Value (US$ Mn) Analysis, by Disease Indication, 2022 to 2032
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Disease Indication, 2022 to 2032
Table 22: North America Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 23: North America Market Value (US$ Mn) Analysis, by Technology, 2022 to 2032
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2032
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2022 to 2032
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032
Table 28: Latin America Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 29: Latin America Market Value (US$ Mn) Analysis, by Application, 2022 to 2032
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032
Table 31: Latin America Market Value (US$ Mn) Analysis, by Disease Indication, 2017 to 2021
Table 32: Latin America Market Value (US$ Mn) Analysis, by Disease Indication, 2022 to 2032
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Disease Indication, 2022 to 2032
Table 34: Latin America Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 35: Latin America Market Value (US$ Mn) Analysis, by Technology, 2022 to 2032
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2032
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2022 to 2032
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032
Table 40: Europe Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 41: Europe Market Value (US$ Mn) Analysis, by Application, 2022 to 2032
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032
Table 43: Europe Market Value (US$ Mn) Analysis, by Disease Indication, 2017 to 2021
Table 44: Europe Market Value (US$ Mn) Analysis, by Disease Indication, 2022 to 2032
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Disease Indication, 2022 to 2032
Table 46: Europe Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 47: Europe Market Value (US$ Mn) Analysis, by Technology, 2022 to 2032
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2032
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2022 to 2032
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032
Table 52: East Asia Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 53: East Asia Market Value (US$ Mn) Analysis, by Application, 2022 to 2032
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032
Table 55: East Asia Market Value (US$ Mn) Analysis, by Disease Indication, 2017 to 2021
Table 56: East Asia Market Value (US$ Mn) Analysis, by Disease Indication, 2022 to 2032
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Disease Indication, 2022 to 2032
Table 58: East Asia Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 59: East Asia Market Value (US$ Mn) Analysis, by Technology, 2022 to 2032
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2032
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2022 to 2032
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2022 to 2032
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Disease Indication, 2017 to 2021
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Disease Indication, 2022 to 2032
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Disease Indication, 2022 to 2032
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by Technology, 2022 to 2032
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2032
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2022 to 2032
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032
Table 76: MEA Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 77: MEA Market Value (US$ Mn) Analysis, by Application, 2022 to 2032
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032
Table 79: MEA Market Value (US$ Mn) Analysis, by Disease Indication, 2017 to 2021
Table 80: MEA Market Value (US$ Mn) Analysis, by Disease Indication, 2022 to 2032
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Disease Indication, 2022 to 2032
Table 82: MEA Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 83: MEA Market Value (US$ Mn) Analysis, by Technology, 2022 to 2032
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2032
Figure 04: Global Market Incremental $ Opportunity, 2022 to 2032
Figure 05: Global Market Share and BPS Analysis by Application, 2022 & 2032
Figure 06: Global Market Y-o-Y Growth Projections by Application, 2022 to 2032
Figure 07: Global Market Attractiveness Analysis by Application, 2022 to 2032
Figure 08: Global Market Share and BPS Analysis by Disease Indication, 2022 & 2032
Figure 09: Global Market Y-o-Y Growth Projections by Disease Indication, 2022 to 2032
Figure 10: Global Market Attractiveness Analysis by Disease Indication, 2022 to 2032
Figure 11: Global Market Share and BPS Analysis by Technology, 2022 & 2032
Figure 12: Global Market Y-o-Y Growth Projections by Technology, 2022 to 2032
Figure 13: Global Market Attractiveness Analysis by Technology, 2022 to 2032
Figure 14: Global Market Share and BPS Analysis by Region, 2022 & 2032
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2022 to 2032
Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2032
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2032
Figure 20: North America Market Incremental $ Opportunity, 2022 to 2032
Figure 21: North America Market Share Analysis by Country, 2022 & 2032
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2022 to 2032
Figure 23: North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 24: North America Market Share and BPS Analysis by Application, 2022 & 2032
Figure 25: North America Market Y-o-Y Growth Projections by Application, 2022 to 2032
Figure 26: North America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 27: North America Market Share and BPS Analysis by Disease Indication, 2022 & 2032
Figure 28: North America Market Y-o-Y Growth Projections by Disease Indication, 2022 to 2032
Figure 29: North America Market Attractiveness Analysis by Disease Indication, 2022 to 2032
Figure 30: North America Market Share and BPS Analysis by Technology, 2022 & 2032
Figure 31: North America Market Y-o-Y Growth Projections by Technology, 2022 to 2032
Figure 32: North America Market Attractiveness Analysis by Technology, 2022 to 2032
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2017 to 2032
Figure 36: Latin America Market Incremental $ Opportunity, 2022 to 2032
Figure 37: Latin America Market Share Analysis by Country, 2022 & 2032
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2022 to 2032
Figure 39: Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 40: Latin America Market Share and BPS Analysis by Application, 2022 & 2032
Figure 41: Latin America Market Y-o-Y Growth Projections by Application, 2022 to 2032
Figure 42: Latin America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 43: Latin America Market Share and BPS Analysis by Disease Indication, 2022 & 2032
Figure 44: Latin America Market Y-o-Y Growth Projections by Disease Indication, 2022 to 2032
Figure 45: Latin America Market Attractiveness Analysis by Disease Indication, 2022 to 2032
Figure 46: Latin America Market Share and BPS Analysis by Technology, 2022 & 2032
Figure 47: Latin America Market Y-o-Y Growth Projections by Technology, 2022 to 2032
Figure 48: Latin America Market Attractiveness Analysis by Technology, 2022 to 2032
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2017 to 2032
Figure 52: Europe Market Incremental $ Opportunity, 2022 to 2032
Figure 53: Europe Market Share Analysis by Country, 2022 & 2032
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2022 to 2032
Figure 55: Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 56: Europe Market Share and BPS Analysis by Application, 2022 & 2032
Figure 57: Europe Market Y-o-Y Growth Projections by Application, 2022 to 2032
Figure 58: Europe Market Attractiveness Analysis by Application, 2022 to 2032
Figure 59: Europe Market Share and BPS Analysis by Disease Indication, 2022 & 2032
Figure 60: Europe Market Y-o-Y Growth Projections by Disease Indication, 2022 to 2032
Figure 61: Europe Market Attractiveness Analysis by Disease Indication, 2022 to 2032
Figure 62: Europe Market Share and BPS Analysis by Technology, 2022 & 2032
Figure 63: Europe Market Y-o-Y Growth Projections by Technology, 2022 to 2032
Figure 64: Europe Market Attractiveness Analysis by Technology, 2022 to 2032
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2017 to 2032
Figure 68: East Asia Market Incremental $ Opportunity, 2022 to 2032
Figure 69: East Asia Market Share Analysis by Country, 2022 & 2032
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2022 to 2032
Figure 71: East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 72: East Asia Market Share and BPS Analysis by Application, 2022 & 2032
Figure 73: East Asia Market Y-o-Y Growth Projections by Application, 2022 to 2032
Figure 74: East Asia Market Attractiveness Analysis by Application, 2022 to 2032
Figure 75: East Asia Market Share and BPS Analysis by Disease Indication, 2022 & 2032
Figure 76: East Asia Market Y-o-Y Growth Projections by Disease Indication, 2022 to 2032
Figure 77: East Asia Market Attractiveness Analysis by Disease Indication, 2022 to 2032
Figure 78: East Asia Market Share and BPS Analysis by Technology, 2022 & 2032
Figure 79: East Asia Market Y-o-Y Growth Projections by Technology, 2022 to 2032
Figure 80: East Asia Market Attractiveness Analysis by Technology, 2022 to 2032
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2017 to 2032
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2022 to 2032
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2022 & 2032
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2022 to 2032
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Application, 2022 & 2032
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2022 to 2032
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Application, 2022 to 2032
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Disease Indication, 2022 & 2032
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Disease Indication, 2022 to 2032
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Disease Indication, 2022 to 2032
Figure 94: South Asia & Oceania Market Share and BPS Analysis by Technology, 2022 & 2032
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by Technology, 2022 to 2032
Figure 96: South Asia & Oceania Market Attractiveness Analysis by Technology, 2022 to 2032
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2017 to 2032
Figure 100: MEA Market Incremental $ Opportunity, 2022 to 2032
Figure 101: MEA Market Share Analysis by Country, 2022 & 2032
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2022 to 2032
Figure 103: MEA Market Attractiveness Analysis by Country, 2022 to 2032
Figure 104: MEA Market Share and BPS Analysis by Application, 2022 & 2032
Figure 105: MEA Market Y-o-Y Growth Projections by Application, 2022 to 2032
Figure 106: MEA Market Attractiveness Analysis by Application, 2022 to 2032
Figure 107: MEA Market Share and BPS Analysis by Disease Indication, 2022 & 2032
Figure 108: MEA Market Y-o-Y Growth Projections by Disease Indication, 2022 to 2032
Figure 109: MEA Market Attractiveness Analysis by Disease Indication, 2022 to 2032
Figure 110: MEA Market Share and BPS Analysis by Technology, 2022 & 2032
Figure 111: MEA Market Y-o-Y Growth Projections by Technology, 2022 to 2032
Figure 112: MEA Market Attractiveness Analysis by Technology, 2022 to 2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What valuation does the venous stents market enjoy at present?
Global demand for venous stents is valued at US$ 1.08 billion in 2022.
At what growth rate is the global venous stents market expected to increase during the next 10 years?
Global sales of venous stents are expected to surge at a CAGR of 8.5% from 2022 to 2032.
What is the venous stents market predicted to be valued by 2032?
The global venous stents market is predicted to reach US$ 2.44 billion by 2032.
What are venous stents made of?
Venous stents are made of metal, usually of high-quality steel and nitenol.
Which are the top venous stent companies?
Key manufacturers of venous stents are Becton, Dickinson Company, Boston Scientific Corporation, Cook Medical LLC, Gore Medical, Jotec GmbH, and OptiMed Medizinische Instrumente GmbH.
Venous Stents Market